| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/11/2003 | US6518264 For treatment/prevention of psychoses, other brain disorders, and cardiovascular disorders |
| 02/11/2003 | US6518251 Macrolides |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | CA2176223C Fenbendazole formulations |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/06/2003 | WO2003010313A1 Novel diphtheria anatoxins and their use as carrier |
| 02/06/2003 | WO2003010191A1 New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialis |
| 02/06/2003 | WO2003009868A1 Antigenic compositions |
| 02/06/2003 | WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/06/2003 | WO2003009833A1 Sustained release delivery system |
| 02/06/2003 | WO2003009812A2 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2000067699A3 Pharmaceutical compositions for treating malaria |
| 02/06/2003 | US20030028034 Nematicidal pyrazoles |
| 02/06/2003 | US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders |
| 02/06/2003 | US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer |
| 02/06/2003 | US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides |
| 02/06/2003 | US20030026822 Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
| 02/06/2003 | CA2454920A1 Antigenic compositions |
| 02/06/2003 | CA2453880A1 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/05/2003 | EP1281397A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 02/05/2003 | EP1280821A1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
| 02/05/2003 | EP0794787B1 Compositions for the treatment of parasitic and fungal infections |
| 02/05/2003 | CN1100788C Peptide for vaccine of schistosomiasis |
| 02/05/2003 | CN1100787C Peptide for vaccine of schisosomiasis |
| 02/05/2003 | CN1100537C Agonists and antagonist for nicotinic acetylcholine receptors of insects to control endoparasites |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514952 For the treatment and prophylaxis of diseases which are caused by an undesired extent of leucocyte adhesion and/or leucocyte migration such as rheumatoid arthritis or allergic disorders |
| 02/04/2003 | US6514945 Azalide antibiotic compositions |
| 02/04/2003 | CA2253490C Use of il-12 and ifn-.alpha. for the treatment of infectious diseases |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008442A1 Novel acyl peptides with leishmanicidal activity |
| 01/30/2003 | WO2003007989A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | WO2003007948A1 Antimalarial agent containing rhodacyanine dye compound |
| 01/30/2003 | WO2003007943A1 Kinase inhibitors and the use thereof |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | WO2002029035A3 Method to alter sugar moieties |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | US20030023081 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 01/30/2003 | US20030022863 Antiadhesive carbohydrates |
| 01/30/2003 | US20030022852 Biodegradable immunomodulatory formulations and methods for use thereof |
| 01/30/2003 | CA2454226A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453602A1 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | CA2452421A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/29/2003 | EP1279735A1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278868A2 Novel mutated form of arginine deiminase |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278767A1 Albumin fusion proteins |
| 01/29/2003 | EP1278759A1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
| 01/29/2003 | EP1278753A2 Peroxide-based antimalarial compounds |
| 01/29/2003 | EP1278544A2 Albumin fusion proteins |
| 01/29/2003 | EP1278528A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 01/29/2003 | EP1278525A2 Methods and compositions for enhancing cellular function through protection of tissue components |
| 01/29/2003 | EP1278520A1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 01/23/2003 | WO2003006996A2 Natural ligand of gpcr chemr23 and uses thereof |
| 01/23/2003 | WO2003006636A1 Reduction of the stimulatory capacity of antigen-presenting cells |
| 01/23/2003 | WO2003006634A2 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 01/23/2003 | WO2003006425A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | WO2003006424A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/23/2003 | WO2003005971A2 Tetracycline compounds having target therapeutic activities |
| 01/23/2003 | WO2002036741A3 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 01/23/2003 | US20030018197 Administering a therapeutically effective amount of a pyrrazole sulfide or ether compound to treat the human immunodeficiency virus infection |
| 01/23/2003 | US20030018186 Monocyclic L-nucleosides, analogs and uses thereof |
| 01/23/2003 | US20030018165 Uses of suppressive macrophage activation factors |
| 01/23/2003 | US20030018049 Azithromycin combination for emesis control in mammals |
| 01/23/2003 | CA2452630A1 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 01/23/2003 | CA2452491A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 01/22/2003 | EP1276856A1 Albumin fusion proteins |
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276747A1 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals |
| 01/22/2003 | EP1276499A2 Equine protozoal myeloencephalitis vaccine |
| 01/22/2003 | EP1276376A1 Active substance combinations with insecticidal and acaricidal properties |
| 01/22/2003 | EP0627004B1 Improvements in or relating to malaria vaccine |
| 01/21/2003 | US6509351 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation |
| 01/21/2003 | US6509015 Human antibodies that bind human TNFa |
| 01/16/2003 | WO2003004683A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 01/16/2003 | WO2003004608A2 Drug metabolizing enzymes |
| 01/16/2003 | WO2003004604A2 Phage displayed pdz domain ligands |
| 01/16/2003 | WO2003004525A2 Isolation and purification of plasmodium falciparum merozoite protein-142 |
| 01/16/2003 | WO2003004065A1 Method of transporting physiological polymer using protein having rxp repeated sequence |
| 01/16/2003 | WO2003004059A1 Treatment of parasitic disease |
| 01/16/2003 | WO2003004010A1 Carbonylamino derivatives useful for obtaining immune regulation |
| 01/16/2003 | WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 01/16/2003 | WO2002038176A3 Immunogenic compositions comprising liver stage malarial antigens |
| 01/16/2003 | WO2002011715A3 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | US20030013860 Azalide isomers, water, and acids |
| 01/16/2003 | US20030013754 Antiinflamamtory agents |
| 01/16/2003 | US20030013681 Complexing with galectins |
| 01/16/2003 | US20030013665 Novel macrolide antibiotics |
| 01/16/2003 | US20030013122 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |